This is a NAN story imho over the next 3-5 yrs; on track to do 25% NAN 2019 revenue, with one panel, of one product line, and a suite of patent protected molecular panels with multi billion markets. The value of this tech eg, most patients have nonspecific symptoms yet a Dr can test for 10-12 conditions at one of the highest levels of accuracy in one test. The stock is approx 60% insto’s / insiders. IMHO Any t/o would need to be in the billions to do justice to the value emerging here
This is a NAN story imho over the next 3-5 yrs; on track to do...
Add GSS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
72.5¢ |
Change
-0.005(0.68%) |
Mkt cap ! $165.6M | |||
| Open | High | Low | Value | Volume |
| 73.0¢ | 73.0¢ | 72.0¢ | $9.952K | 13.74K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 17065 | 71.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 72.5¢ | 469 | 2 |
View Market Depth
| Last trade - 11.44am 13/09/2024 (20 minute delay) ? |
| GSS (ASX) Chart |